Famciclovir (Page 9 of 9)

Package/Label Display Panel

NDC 0093-8117-56

Famciclovir
Tablets125 mg

PHARMACIST: PLEASE DISPENSE WITH

ATTACHED PATIENT INFORMATION LEAFLET

Rx only

30 TABLETS

Label 125 mg. 30 Tablets
(click image for full-size original)

Package/Label Display Panel

NDC 0093-8118-56

Famciclovir
Tablets250 mg

PHARMACIST: PLEASE DISPENSE WITH

ATTACHED PATIENT INFORMATION LEAFLET

Rx only

30 TABLETS

Label 250 mg, 30 Tablets
(click image for full-size original)

Package/Label Display Panel

NDC 0093-8119-56

Famciclovir
Tablets500 mg

PHARMACIST: PLEASE DISPENSE WITH

ATTACHED PATIENT INFORMATION LEAFLET

Rx only

30 TABLETS

Label 500 mg, 30 Tablets
(click image for full-size original)
FAMCICLOVIR famciclovir tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-8117
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FAMCICLOVIR (PENCICLOVIR) FAMCICLOVIR 125 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
HYPROMELLOSE 2910 (50 MPA.S)
POLYDEXTROSE
POLYETHYLENE GLYCOL, UNSPECIFIED
SILICON DIOXIDE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
SODIUM STEARYL FUMARATE
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color white Score no score
Shape ROUND Size 8mm
Flavor Imprint Code 8117;93
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-8117-56 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077487 09/05/2007
FAMCICLOVIR famciclovir tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-8118
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FAMCICLOVIR (PENCICLOVIR) FAMCICLOVIR 250 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
HYPROMELLOSE 2910 (50 MPA.S)
POLYDEXTROSE
POLYETHYLENE GLYCOL, UNSPECIFIED
SILICON DIOXIDE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
SODIUM STEARYL FUMARATE
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color white Score no score
Shape ROUND Size 10mm
Flavor Imprint Code 8118;93
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-8118-56 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077487 09/05/2007
FAMCICLOVIR famciclovir tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0093-8119
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FAMCICLOVIR (PENCICLOVIR) FAMCICLOVIR 500 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
HYPROMELLOSE 2910 (3 MPA.S)
HYPROMELLOSE 2910 (6 MPA.S)
HYPROMELLOSE 2910 (50 MPA.S)
POLYDEXTROSE
POLYETHYLENE GLYCOL, UNSPECIFIED
SILICON DIOXIDE
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
SODIUM STEARYL FUMARATE
TITANIUM DIOXIDE
TRIACETIN
Product Characteristics
Color white Score no score
Shape OVAL (capsule-shaped) Size 18mm
Flavor Imprint Code 8119;93
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0093-8119-56 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077487 09/05/2007
Labeler — Teva Pharmaceuticals USA, Inc. (001627975)

Revised: 12/2018 Teva Pharmaceuticals USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.